Arrowhead Pharmaceuticals Corp (ARWR) Misses Q3 EPS by 8c, Revenues Miss

August 5, 2019 4:01 PM

Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) reported Q3 EPS of $0.21 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found